Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.52 USD | +5.71% | +3.24% | +37.90% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.